The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carragher, D.
Right arrow Articles by Caamaño, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carragher, D.
Right arrow Articles by Caamaño, J.
The Journal of Immunology, 2004, 173: 2271-2279.
Copyright © 2004 by The American Association of Immunologists

A Stroma-Derived Defect in NF-{kappa}B2–/– Mice Causes Impaired Lymph Node Development and Lymphocyte Recruitment1

Damian Carragher*,{ddagger}, Ramneek Johal{dagger},{ddagger}, Adele Button*,{ddagger}, Andrea White*,{ddagger}, Aristides Eliopoulos{ddagger},§, Eric Jenkinson*,{ddagger}, Graham Anderson*,{ddagger} and Jorge Caamaño2,{dagger},{ddagger}

* Department of Anatomy, {dagger} Division of Infection and Immunity, {ddagger} Medical Research Council Centre for Immune Regulation, and § Cancer Research United Kingdom Institute for Cancer Studies, The Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The NF-{kappa}B family of transcription factors is vital to all aspects of immune function and regulation in both the hemopoietic and stromal compartments of immune environments. Recent studies of mouse models deficient for specific members of the NF-{kappa}B family have revealed critical roles for these proteins in the process of secondary lymphoid tissue organogenesis. In this study, we investigate the role of NF-{kappa}B family member NF-{kappa}B2 in lymph node development and lymphocyte recruitment. Inguinal lymph nodes in nf{kappa}b2–/– mice are reduced in size and cellularity, most notably in the B cell compartment. Using in vitro and in vivo lymph node grafting assays, we show that the defect resides in the stromal compartment. Further examination of the nf{kappa}b2–/– inguinal lymph nodes revealed that expression of peripheral node addressin components CD34 and glycosylation-dependent cell adhesion molecule-1 along with the high endothelial venule-restricted sulfotransferase HEC-GlcNAc6ST was markedly reduced. Furthermore, expression of the lymphocyte homing chemokines CCL19, CCL21, and CXCL13 was down-regulated. These data highlight the role of NF-{kappa}B2 in inguinal lymph node organogenesis and recruitment of lymphocytes to these organs due to its role in up-regulation of essential cell adhesion molecules and chemokines, while suggesting a potential role for NF-{kappa}B2 in organization of lymph node endothelium.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Lymph nodes (LN)3 and Peyer’s patches (PP) are highly organized secondary lymphoid organs where the essential interactions between lymphocytes and dendritic cells take place during the initial steps of adaptive immune responses.

Among the early events that give rise to LNs during embryonic development is the transendothelial migration of CD45+CD4+CD3IL-7R{alpha}+{alpha}4{beta}7+ cells (inducer cells) to colonize LN anlagen (for review on inducer cells, see Ref.1). Inducer cells express high levels of the membrane-bound ligand lymphotoxin {alpha}1{beta}2 (LT{alpha}1{beta}2), which upon binding to LT{beta}R on mesenchymal cells (organizer cells) stimulates expression of VCAM-1, ICAM-1, and the homing chemokines CXCL13/B lymphocyte chemoattractant, CCL19/EBV-induced molecule 1 ligand chemokine, and CCL21/secondary lymphoid tissue chemokine (2, 3). These chemokines induce a feedback loop that attracts large numbers of further inducer cells expressing the CXCL13 receptor, CXCR5, as well as the receptor for CCL19 and CCL21, CCR7 (3, 4). Clustering of these inducer cells with stromal cells of the LN anlagen is a vital part of further productive LN development (5, 6) (for review, see Ref.7).

A few days after birth, a switch in the expression of adhesion molecules in high endothelial venules (HEVs) occurs. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) levels are reduced, and peripheral node addressin (PNAd) expression is observed, facilitating the homing of L-selectin+ lymphocytes to LNs (8). The chemokines CCL21, CCL19, CXCL13, and CXCL12/stromal cell-derived factor-1 together with PNAd participate in transendothelial migration of lymphocytes into LNs and PPs (9, 10). Lymphocyte recruitment creates a positive feedback loop between B cells and stromal cells mediated by CXCL13/CXCR5 signaling in the former and LT{alpha}1{beta}2/LT{beta}R in the latter (11).

Cross talk interactions between hemopoietic and stromal cells during LN development are mediated by LT{alpha}1{beta}2/LT{beta}R, TNF-related activation-induced cytokine (TRANCE)/TRANCE-R, TNF-{alpha}/TNF-RI, and CXCL13/CXCR5. Gene knockout experiments have revealed that lt{alpha}–/– and lt{beta}r–/– mice lack all LNs and PPs, while lt{beta}–/– mice have only mucosal LNs (12, 13). Likewise, trance–/– mice present with rudimentary LNs containing a reduced number of inducer cells (5). Signaling through LT{alpha}1{beta}2/LT{beta}R and, to a lesser degree, LT{alpha}3/TNFR-I cooperates in the development of LNs and PPs (13, 14, 15).

Importantly, LT{beta}R, TRANCE-R, and TNF-RI signaling pathways converge in activation of the NF-{kappa}B family of transcription factors. The Rel/NF-{kappa}B proteins regulate transcription of a large number of cellular genes involved in innate and adaptive immune and inflammatory responses (16, 17, 18). Mammalian cells express five NF-{kappa}B proteins: NF-{kappa}B1 (the DNA-binding subunit p50 and its precursor p105), NF-{kappa}B2 (the DNA-binding subunit p52 and its precursor p100), RelA (p65), RelB, and c-Rel. Nonstimulated cells contain cytoplasmic homo- and heterodimers of these factors bound to a family of I{kappa}Bs. Activation of NF-{kappa}B occurs via at least two distinct pathways (19). Signaling through the TNF-RI and other proinflammatory cytokine receptors activates the classical NF-{kappa}B pathway through the I{kappa}B kinase (IKK) signalosome complex, containing the I{kappa}B kinases {alpha} and {beta} (IKK{alpha}, IKK{beta}), and a regulatory subunit, IKK{gamma}/NF-{kappa}B essential modulator, induces phosphorylation and subsequent degradation of I{kappa}B{alpha} facilitating nuclear translocation of p50/RelA dimers. In contrast, LT{beta}R signals through both the classical and the alternative NF-{kappa}B pathway that through the NF-{kappa}B-inducing kinase (NIK) and an IKK{alpha} complex induces the processing of NF-{kappa}B2 p100 to p52 and the nuclear translocation of p52/RelB (20, 21, 22, 23, 24, 25, 26).

The NF-{kappa}B proteins have specific functions during secondary lymphoid tissue organogenesis (27). We and others have shown that nf{kappa}b2–/– mice present with marked defects in the architecture of the spleen, and lack follicular dendritic cells due to defects in stromal cells (28, 29, 30). Interestingly, relB–/– mice have similar defects due to impairment in stromal cells (31, 32). RelA has an important function in stromal cells during LN development, as shown by the absence of LNs in relA–/–/tnfr1–/– mice (33). Similarly, wnt-I{kappa}B{alpha} dominant-negative mice lack LNs, due to inhibition of Rel-A-containing complexes (34)

Abnormal splenic architecture, follicular dendritic cell maturation, and PP development in NIK (nik–/– mice and aly/aly mice) or IKK{alpha}aa kinase mutant mice demonstrated the role of these two kinases during the organization of secondary lymphoid tissues (35, 36, 37).

In this study, we analyze the role of NF-{kappa}B2 during LN development and lymphocyte recruitment to LNs. We show that nf{kappa}b2–/– mice have a defect in the development of inguinal LNs (ILNs) with a remarkable decrease of lymphocyte numbers. We have developed a series of in vivo and ex vivo assays to investigate whether NF-{kappa}B2 is required cell autonomously in bone marrow-derived or stromal cells during LN organization. We find that nf{kappa}b2–/– lymphocytes are able to populate wild-type ILNs, whereas nf{kappa}b2+/+ lymphocytes are dramatically impaired in their migration into nf{kappa}b2–/– ILNs due to an intrinsic defect in the stromal cells of these organs. Our results demonstrate that NF-{kappa}B2 has an important function in stromal cells in regulating the expression of the cell adhesion molecules and chemokines required for proper LN organogenesis and to drive lymphocyte transendothelial migration into these organs.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

The generation of nf{kappa}b2–/– mice has been previously described (28). Mice were backcrossed >10 generations in C57BL/6J background. CD45.1 congenic mice were obtained from The Jackson Laboratory (Bar Harbor, ME). All animals were bred and maintained at the Biomedical Service Unit of the University of Birmingham according to Home Office regulations.

LN dissection and immunostaining

LNs were dissected from the different mouse strains, embedded in OCT compound, snap frozen in liquid N2, and stored at –70°C until further use. Sections (5 µm) were cut using a cryostat and serially mounted onto multispot slides. Tissue sections were air dried, acetone fixed, and stored at –20°C. Slides were washed in Tris buffer, pH 7.6, and primary Abs were added and incubated at room temperature for 45 min. Abs used in this study were: anti-CD3, anti-IgD, anti-CD45.2, anti-MAdCAM-1, MECA-79 (BD Pharmingen, San Diego, CA), anti-CXCL13 (R&D Systems, Minneapolis, MN), and biotinylated-Lycopersicon Esculentum (tomato) lectin, which binds to N-acetylglucosamine groups. Slides were washed, and secondary Abs were added for 45 min. After further washes, the streptavidin-biotin complex was added for 30 min. Color was developed with diaminobenzidine peroxidase. Alkaline phosphatase was developed using Fast blue and Naphthol AS-MX phosphate.

Neonatal LN colonization assays

CD4+ cells were isolated from postnatal day 3 (P3) thymi by magnetic bead depletion of CD8+ cells, followed by staining for CD4 PE (BD Pharmingen), and positively sorted for PE+ cells using a magnetism-assisted cell-sorting column method (MiniMACS). The resulting population was analyzed for CD4 expression via FACS (BD Biosciences, San Jose, CA). Nf{kappa}b2–/– CD4+ cells were labeled with CFSE, while the nf{kappa}b2+/+ CD4+ cells were stained with PKH 2.6 (Sigma-Aldrich, St. Louis, MO). ILNs were excised from P2 nf{kappa}b2+/+ and nf{kappa}b2–/– mice and cultured in the presence of 1 x 105 labeled cells in a hanging drop system in Terasaki plates for 24 h before analysis by FACS or immunofluorescence on frozen sections.

Semiquantitative (Sq) RT-PCR

LNs were excised and disaggregated with trypsin/EDTA. The resulting cell suspension was depleted of CD45+ cells via magnetic depletion beads (Dynal Biotech, Great Neck, NY). Cells were snap frozen, RNA extraction was performed using TRIzol (Sigma-Aldrich), and cDNA was synthesized with Moloney murine leukemia virus reverse transcriptase (Invitrogen Life Technologies, Carlsbad, CA). Sq RT-PCR was undertaken on neonatal LN stroma or ILNs using primers that have been previously described (31, 38). PCR products were separated by electrophoresis in 1.8% agarose gels and visualized on a Syngene gene viewer.

Cell counts, FACS, and statistical analyses

Superficial inguinal, axillary, and mesenteric LNs were isolated, and a single cell suspension was prepared by teasing the organs with a needle and forceps. Cells were counted in the presence of trypan blue and labeled with mAbs anti-CD3, anti-CD4, anti-CD8, anti-B220, anti-CD19, anti-CD45.1, anti-CD45.2, anti-IL-7R{alpha}, and anti-annexin V (BD Pharmingen). Ten thousand events were collected and analyzed on a FACSCalibur (BD Biosciences). Cells were isolated from one ILN per mouse, and six mice per genotype were used in each assay. Statistical analyses were performed using the Mann-Whitney two-tailed test.

LN grafting

ILNs were excised from P2 nf{kappa}b2+/+ and nf{kappa}b2–/– mice and grafted by surgical procedure under the kidney capsule of 6- to 8-wk-old Ly-5.1 or Ly-5.2 C57BL6J nf{kappa}b2+/+ or Ly-5.2 C57BL6J nf{kappa}b2–/– mice. Grafts and host ILNs were extracted after 2 wk and analyzed by FACS analysis or immunostaining.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Impaired LN development in nf{kappa}b2–/– mice

During the course of previous studies on nf{kappa}b2–/– mice, we observed that peripheral LNs, in particular inguinal and popliteal LNs of adult mice, were dramatically reduced in size compared with LNs of nf{kappa}b2+/+ littermates (Fig. 1A). This fact prompted us to pursue a thorough analysis of these organs to understand the cause of this impairment. Further observation demonstrated that adult nf{kappa}b2–/– mice lack popliteal LNs. In addition, 40% of the adult nf{kappa}b2–/– mice analyzed (n = 20) have very rudimentary ILNs that contain mainly stromal cells and very few lymphocytes, which makes their study rather difficult. However, the remaining 60% of adult nf{kappa}b2–/– ILNs, although reduced in size, were large enough to allow further studies. Absolute cell numbers, but not percentages, of CD4+ and CD8+ T cells, were found to be reduced in the ILNs of nf{kappa}b2–/– mice compared with nf{kappa}b2+/+ littermates (Fig. 1, B–D): the mean of CD4+ T cells is 6-fold lower in nf{kappa}b2–/– ILNs (nf{kappa}b2+/+, 8.49 x 105 cells SEM 1.39 x 105; nf{kappa}b2–/–, 1.38 x 105 cells SEM 2.53 x 104 (p < 0.0043)). Moreover, the number of B220+ B cells was found to be reduced 12-fold compared with nf{kappa}b2+/+ ILNs (nf{kappa}b2+/+, 2.78 x 105 cells SEM 5.7 x 104; nf{kappa}b2–/–, 2.24 x 104 cells SEM 3.8 x 103 (p < 0.0043)), as well as a reduction in the percentage of B cells also being noted (Fig. 1, E and F). Annexin V staining and FACS analysis of cells recovered from ILN nf{kappa}b2–/– mice showed an increase in the frequency of cells undergoing apoptosis, compared with nf{kappa}b2+/+ mice (nf{kappa}b2+/+, 45.5% SEM 2.3; nf{kappa}b2–/–, 81.5% SEM, 5.5, n = 6, p < 0.0022) (data not shown). Immunohistochemical analysis of T and B cell distribution in the ILNs from adult nf{kappa}b2+/+ mice (Fig. 1, G and I) and nf{kappa}b2–/– (Fig. 1, H and J) mice shows that the latter form only small IgD+ B cell areas in the cortex of the LNs (Fig. 1, G and H). Many nf{kappa}b2–/– B cells were scattered among CD3+ T cells in the paracortex of the LNs (arrowheads, Fig. 1H). Large numbers of B cells were seen surrounding large HEVs in nf{kappa}b2+/+ ILNs, but only few B cells were observed around small-sized HEVs in nf{kappa}b2–/– ILNs (Fig. 1, G and H). Furthermore, higher magnification of tissue sections shows that in contrast to the well-organized B cell areas present in nf{kappa}b2+/+ ILNs (Fig. 1I), B cell areas in nf{kappa}b2–/– ILNs are small and poorly organized (Fig. 1, I and J). Immunofluorescence staining of ILNs excised from 7-day-old mice with anti-CD45.2 Abs showed an almost complete absence of bone marrow-derived cells in organs from nf{kappa}b2–/– mice compared with nf{kappa}b2+/+ littermates (Fig. 1, K and L). Taken together, these results show a paucity of T and B cells in ILNs of both adult and perinatal nf{kappa}b2–/– mice. A higher percentage of CD4+CD3 cells was observed in ILNs of nf{kappa}b2–/– neonates compared with nf{kappa}b2+/+ littermates (Fig. 2A). Inducer cells from nf{kappa}b2+/+ and nf{kappa}b2–/– mice expressed similar levels of IL-7R{alpha} on their surface (Fig. 2B).



View larger version (51K):
[in this window]
[in a new window]
 
FIGURE 1. Impaired LN development in nf{kappa}b2–/– mice. A, ILNs from 8-wk-old nf{kappa}b2+/+ and nf{kappa}b2–/– littermate mice were isolated and analyzed on a dissection microscope (x4). Note the small size of the nf{kappa}b2–/– ILN compared with its WT littermate. B, nf{kappa}b2–/– ILNs have very low numbers of cells compared with WT littermates. Single-cell suspensions from nf{kappa}b2+/+ ({blacksquare}) and nf{kappa}b2–/– mice () ILNs were counted and analyzed by FACS for CD4+ T cells and B220+ B cells. Results shown correspond to the mean and SEM from two separate experiments using one ILN from six mice of each genotype per assay. Statistical analyses were performed by Mann-Whitney two-tailed test and showed very significant differences (p < 0.0043) between the two populations analyzed. Similar results were obtained in four independent experiments. C and D, FACS analyses of LN cells from nf{kappa}b2+/+ (C) and nf{kappa}b2–/– (D) littermate mice stained with anti-CD4-FITC and anti-CD8-PE mAbs. E and F, Histogram plots showing the percentage of B220+ B cells from ILNs of nf{kappa}b2+/+ (E) and nf{kappa}b2–/– (F) littermate mice. G–J, Immunostaining of representative sections of ILNs from adult nf{kappa}b2+/+ (G and I) and nf{kappa}b2–/– (H and J) littermates stained with anti-IgD (brown) for B cells and anti-CD3 (blue) for T cells. The rectangles highlight the areas that are magnified in I and J. Full circles in G and H indicate paracortical T cell areas. Arrow on G indicates B cells surrounding an HEV. Arrowheads in H indicate B cells present in the paracortex of the ILN of nf{kappa}b2–/– mice. Note the reduced number of B cells present in the nf{kappa}b2–/– ILN. K and L, Fluorescence micrograph of representative sections of ILNs from 7-day-old nf{kappa}b2+/+ (K) and nf{kappa}b2–/– (L) mice stained with anti-CD45.2 (green) and anti-PNAd (red). Note the low numbers of CD45.2+ bone marrow-derived cells present in the section of the nf{kappa}b2–/– ILN. Magnification x20 (G and H) and x40 (I–L).

 


View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 2. Inducer cells are present in ILN of nf{kappa}b2–/– mice. A, FACS analyses of single cell suspensions from ILNs of 2-day-old WT and nf{kappa}b2–/– mice stained with anti-CD3-FITC/anti-CD4-PE. A higher percentage of CD4+/CD3 cells was observed in ILN of nf{kappa}b2–/– mice. B, Expression of IL-7R{alpha} on CD4+/CD3 inducer cells is similar in WT and nf{kappa}b2–/– mice. Vertical lines in the histograms represent levels of background staining controls. Gated inducer cells were stained for IL-7R{alpha} and analyzed.

 
LN organ cultures show a defect in nf{kappa}b2–/– stromal cells

To analyze whether the paucity of lymphocytes in nf{kappa}b2–/– LNs is due to intrinsic defects in lymphocytes or to defects in the stromal compartment, we established an organ culture system (LN organ culture) to study LN colonization under defined in vitro conditions (Fig. 3A). Single-positive CD4+ thymocytes from nf{kappa}b2+/+ and nf{kappa}b2–/– mice were labeled with fluorescent tracker dyes. Equal numbers of cells were then placed in hanging drop cultures with alymphoid LNs of P2 wild-type (WT) or rag1–/– mice, and cell migration was assessed after 24 h by FACS. These assays showed that similar numbers of nf{kappa}b2–/– and nf{kappa}b2+/+ CD4+8 cells had migrated into WT LNs (Fig. 3, A and B, and data not shown). In contrast, migration of cells to nf{kappa}b2–/– ILNs was reduced as compared with WT ILNs, regardless of whether the CD4+ cells were WT or nf{kappa}b2–/– (Fig. 3B). Taken together, these results suggest that the reduced cellularity of ILNs in nf{kappa}b2–/– mice is due to a defect in stromal and/or endothelial cells rather than being intrinsic to lymphoid cells. However, the reduced size of nf{kappa}b2–/– ILNs compared with WT ILNs implies that fewer niches might be available to be colonized by lymphocytes, and thus results in small number of CD4+ cells migrating to the organs. Our studies show that nf{kappa}b2–/– CD4+ cells are capable of competing effectively with WT cells in their migration to LNs.



View larger version (95K):
[in this window]
[in a new window]
 
FIGURE 3. A defect in the stromal compartment of the LNs of nf{kappa}b2–/– mice is responsible for the reduced colonization of lymphocytes to these organs. A, LN organ culture assay. CD4+ cells labeled with Thy-1.2+ FITC (arrowheads) had migrated into an alymphoid P2 rag1–/– ILN after 24 h in culture. B, nf{kappa}b2–/– ILNs are colonized by low numbers of CD4+ thymocytes compared with nf{kappa}b2+/+ ILNs. CD4+CD8 thymocytes from littermate mice were labeled, as described in Materials and Methods, and used in LN organ culture assays on nf{kappa}b2+/+ and nf{kappa}b2–/– LNs. The organs were disaggregated, and cells were counted and analyzed by FACS. Note that nf{kappa}b2–/– CD4+ cells were able to colonize nf{kappa}b2+/+ ILN and compete with nf{kappa}b2+/+ cells. C, Neonate ILNs grafted under the kidney capsule of adult mice are populated by host cells. Photomicrograph of a kidney of an adult nf{kappa}b2–/– mouse carrying a 2-wk-old graft nf{kappa}b2+/+ ILN under the capsule. D, Similar as C, but showing an nf{kappa}b2–/– ILN grafted on a nf{kappa}b2+/+ mouse. LN grafts in C and D are highlighted by a blue box. Yellow box in D highlights the kidney capsule shown at higher magnification in F. E, Comparison of inguinal and mesenteric LNs from the nf{kappa}b2–/– recipient mouse and the nf{kappa}b2+/+ ILN graft from C. F, Same as E, showing inguinal and mesenteric LNs from the nf{kappa}b2+/+ recipient mouse and the nf{kappa}b2–/– ILN graft from D (blue rectangle) and surrounding kidney capsule (yellow rectangle).

 
NF-{kappa}B2 function is required in stromal cells, but not in lymphocytes for LN colonization

We next tested whether nf{kappa}b2–/– LNs can be colonized by lymphocytes in vivo. ILNs from neonatal nf{kappa}b2–/– and WT littermates were grafted under the kidney capsule of WT and nf{kappa}b2–/– adult mice, respectively (Fig. 3, C–F) (39, 40, 41). After 2 wk, kidneys were dissected, and the grafts were analyzed. Fig. 3C (blue box) shows a WT ILN grafted in an nf{kappa}b2–/– adult mouse, while Fig. 3D (blue box) shows an nf{kappa}b2–/– ILN grafted in a WT adult mouse. Although the WT ILNs recovered were consistently found to have grown in size, recovered nf{kappa}b2–/– ILNs remained small, and in some cases could not be distinguished from the kidney capsule (Fig. 3, C–F). Moreover, nf{kappa}b2–/– LNs grafted into WT hosts were found to be devoid of viable lymphocytes (Fig. 4C). In marked contrast, viable T and B cells were readily recovered from WT ILNs grafted into nf{kappa}b2–/– mice (Fig. 4A).



View larger version (48K):
[in this window]
[in a new window]
 
FIGURE 4. Neonate WT ILNs grafted on nf{kappa}b2–/– mice were colonized by lymphocytes from the host. A, WT Ly-5.1 ILN grafted on nf{kappa}b2–/– Ly-5.2 adult mice was colonized by CD4+ and CD8+ T cells and CD19+ B cells from the host. B, Bone marrow-derived cells migrating into grafted LNs are of host origin. Single cell suspensions from ILNs of nf{kappa}b2–/– (CD45.2) recipient mice and WT (CD45.1) donor grafts were analyzed by FACS for the expression of the CD45.1/CD45.2 alleles to identify the origin of cells migrating to the graft. As shown here, >90% of the cells are of host origin. C, nf{kappa}b2–/– ILN grafted on nf{kappa}b2+/+ adult mice was not colonized by lymphocytes from the host and contains dead cells. D–F, Immunofluorescence staining of an ILN section from the nf{kappa}b2–/– recipient mouse from A and B (D), nf{kappa}b2+/+ recipient mouse from C (E), and nf{kappa}b2+/+ ILN graft from A (F) for B220+ B cells (green) and CD3+ T cells (red). Note the small and loosely pack B cell area in the nf{kappa}b2–/– ILN (D) compared with the same area on the nf{kappa}b2+/+ graft ILN (F) and the nf{kappa}b2+/+ ILN (E).

 
Importantly, when we performed similar grafting experiments in a CD45.1/CD45.2 congenic system, we could clearly demonstrate that the vast majority (in all cases 90% or greater) of the CD4+ and CD8+, as well as the CD19+ B cells present within WT (CD45.1) ILN grafts, were of recipient nf{kappa}b2–/– CD45.2 origin, and not from cells pre-existing within the graft (Fig. 4B).

Analysis of the distribution and organization of lymphocytes in the WT ILNs grafted into nf{kappa}b2–/– adults showed well-organized B and T cell areas (Fig. 4F), which were indistinguishable from adult WT ILNs (Fig. 4E). In contrast, small and disorganized B cell areas were present in the recipient nf{kappa}b2–/– adults’ own ILNs (Fig. 4D). Therefore, when a WT LN microenvironment is provided, nf{kappa}b2–/– lymphocytes are capable of effective transendothelial migration into LNs and form compartmentalized B and T cell areas.

Expression of cell adhesion molecules is reduced in nf{kappa}b2–/– inguinal LNs

Analysis of the expression of cell adhesion molecules and receptors involved in lymphocyte migration into LNs, such as MAdCAM-1 and PNAd, in nf{kappa}b2+/+ and nf{kappa}b2–/– ILNs at different stages showed that these molecules were expressed at similar levels in both mice at P3 (data not shown). However, by P7, both PNAd and MAdCAM-1 were markedly reduced in the nf{kappa}b2–/– mice (Fig. 5, A and B, and data not shown). Similarly, sections of 14- and 25-day-old nf{kappa}b2–/– ILNs showed low levels of expression of PNAd (Fig. 5, C–F). Interestingly, ILNs from adult nf{kappa}b2–/– mice displayed a pattern of PNAd staining that resembles that of P7 nf{kappa}b2+/+ ILNs (Figs. 5, G and H, and 6, B and D). Close examination of PNAd expression in nf{kappa}b2–/– ILNs indicated a delay in the development and organization of the vessels, as shown by the few PNAd+ HEVs compared with the complexity of the HEV network in nf{kappa}b2+/+ ILNs and by the poorly organized PNAd+ and tomato lectin+ cells in ILNs of adult nf{kappa}b2–/– mice (Figs. 5 and 6, A and B). The calibre of the HEVs in nf{kappa}b2–/– ILNs was consistently reduced compared with nf{kappa}b2+/+ HEVs (Fig. 5, A–H).



View larger version (133K):
[in this window]
[in a new window]
 
FIGURE 5. Reduced expression of PNAd in LNs of nf{kappa}b2–/– mice. Immunostaining of LN sections of nf{kappa}b2+/+ mice (A, C, E, and G) and nf{kappa}b2–/– mice (B, D, F, and H) for IgD+ B cells (brown) and the MECA79 Ab (blue), which recognizes a sugar moiety present in different PNAd such as CD34 and GlyCAM-1. A and B correspond to 7-day-old mice, C and D to 14-day-old mice, E and F to 25-day-old mice, and G and H to 3-mo-old mice. Arrowheads indicate PNAd+ HEVs, and the stars indicate B cell areas.

 


View larger version (57K):
[in this window]
[in a new window]
 
FIGURE 6. PNAd and tomato lectin staining in adult nf{kappa}b2–/– ILNs. Immunofluorescence staining of ILN sections of adult nf{kappa}b2+/+ mice (A), nf{kappa}b2–/– mice (B), a 2-wk-old nf{kappa}b2+/+ ILN grafted into a nf{kappa}b2–/– mouse (C), and a neonate nf{kappa}b2+/+ ILN (D) with MECA79 mAb (red) and tomato lectin (green). Note the PNAd luminal (star) and the tomato lectin abluminal staining (arrowhead) in nf{kappa}b2+/+ ILN (A) and the nf{kappa}b2+/+ graft (C) and the poorly organized HEV structure in nf{kappa}b2–/– ILN (B), which resembles the staining seen in neonate nf{kappa}b2+/+ ILNs (D). E, Sq reverse transcription and PCR amplification (Sq RT-PCR) of cell adhesion molecules GlyCAM-1, CD34, VCAM-1, and {beta} actin as loading control. RNA was isolated from 14-day-old ILNs from nf{kappa}b2+/+ and nf{kappa}b2–/– mice, used to synthesize cDNA, and subjected to PCR amplification, as described in Materials and Methods. Lanes 1 and 7 correspond to 24 PCR cycles; lanes 2 and 8 to 28 cycles; lanes 3 and 9 to 32 cycles; lanes 4 and 10 to 36 cycles; lanes 5 and 11 to 40 cycles; and lanes 6 and 12 to 44 cycles. Note the marked reduction of expression of CD34 and GlyCAM-1 in the samples from nf{kappa}b2–/– mice. F, Sq RT-PCR of cell adhesion molecules in adult ILNs from nf{kappa}b2+/+ and nf{kappa}b2–/– mice. The expression of {beta} actin, GlyCAM-1, CD34, and VCAM-1 was analyzed, as in E. Note the lower expression of CD34 and GlyCAM-1 in the samples from nf{kappa}b2–/– mice. Similar levels of VCAM-1 expression are shown in 14-day-old and adult tissues of nf{kappa}b2+/+ and nf{kappa}b2–/– mice.

 
Sq RT-PCR analysis confirmed our results in that mRNA levels of madcam-1 and the PNAd, glycam-1 and cd34, were markedly reduced in 14-day-old and adult nf{kappa}b2–/– ILNs compared with the nf{kappa}b2+/+ ILNs (Fig. 6, E and F). Furthermore, the expression of the HEV-restricted sulfotransferase high endothelial cell-GlcNAc6 sulfotransferase (HEC-GlcNAc6ST) is strikingly decreased in nf{kappa}b2–/– ILNs (42, 43). Lymphocytes from the nf{kappa}b2–/– mice expressed similar levels of the PNAd receptor, L-selectin, and LFA-1 as their WT littermates (data not shown). These results clearly show that NF-{kappa}B2 is necessary for the normal expression of MAdCAM-1, glycosylation-dependent cell adhesion molecule (GlyCAM-1), and CD34.

NF-{kappa}B2 is necessary for the expression of CXCL13/B lymphocyte chemoattractant, CCL21/secondary lymphoid tissue chemokine, and CCL19/EBV-induced moleldule 1 ligand chemokine

The reduced number of lymphocytes recruited to nf{kappa}b2–/– ILNs prompted us to analyze the expression of the chemokines that facilitate lymphocyte transmigration of HEVs in LNs of adult mice (9, 10). Immunostaining of CXCL13 in ILNs showed a marked reduction at day 7–14 in nf{kappa}b2–/– mice, and it was undetectable in older mice compared with WT littermates (Fig. 7A, and data not shown). Similarly, CD45 stromal cells from 3-day-old nf{kappa}b2–/– ILNs had noticeably lower mRNA levels of cxcl13, ccl21, and ccl19 compared with nf{kappa}b2+/+ littermates (Fig. 7B). The impaired expression of CXCL13 and CCL21 was further confirmed in 14-day-old nf{kappa}b2–/– ILNs (Fig. 7C). These results indicate a defect in stromal and endothelial cells in the absence of NF-{kappa}B2. Normal levels of cxcl12 and eotaxin expression were observed in nf{kappa}b2–/– ILNs (Fig. 7, B and C). Sq RT-PCR analysis of cxcr5, ccr7, and cxcr4 showed no significant differences in the levels of these receptors in lymphocytes of nf{kappa}b2–/– and nf{kappa}b2+/+ mice (data not shown) (31).



View larger version (94K):
[in this window]
[in a new window]
 
FIGURE 7. Low expression of homing chemokines in LNs of nf{kappa}b2–/– mice. A, Immunostaining of ILN sections of adult nf{kappa}b2+/+ and nf{kappa}b2–/– mice with anti-CXCL13 antiserum (blue) and anti-IgD mAb (brown). Arrowheads indicate the presence of CXCL13 staining in endothelium of nf{kappa}b2+/+ mice. Stars indicate B cell areas. Note the absence of CXCL13 staining in nf{kappa}b2–/– mice and the low number of B cells. B, Sq RT-PCR of the chemokines CCL19, CCL21, CXCL13, CXCL12, eotaxin, and {beta} actin as loading control. RNA was isolated from CD45 stromal cells from ILNs of 3-day-old nf{kappa}b2+/+ and nf{kappa}b2–/– mice. PCR amplification was performed as in Fig. 6E. Note the marked decreased expression of CXCL13, CCL21, and CCL19 in the samples from nf{kappa}b2–/– mice. C, Sq RT-PCR of chemokine genes in 14-day-old ILNs from nf{kappa}b2+/+ and nf{kappa}b2–/– mice. Chemokine expression was analyzed, as in B.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
LN development involves interactions between bone marrow-derived inducer cells and stromal organizer cells to form cell clusters in the LN anlagen (7). Among the signals that mediate the cross talk between these cells as well as between lymphocytes and stromal cells in mature LNs, LT{alpha}1{beta}2 binding to LT{beta}R activates the classical and the alternative NF-{kappa}B pathways in stromal cells, resulting in nuclear translocation of p50/RelA and p52/RelB, respectively. In this study, we set forth to investigate the function of NF-{kappa}B2 p52 during LN development and show that p52 is cell autonomously required on LN stromal cells for the development of these organs.

Our study shows that in nf{kappa}b2–/– mice, ILNs are rudimentary, and have paucity of B cells compared with their WT counterparts. We established LN organ cultures and neonatal LN grafting assays to demonstrate that nf{kappa}b2–/– lymphocytes are fully capable of migrating into WT ILNs, and the BAFF-R/BR3 signaling defect in nf{kappa}b2–/– B cells does not play an important role in this process (44). Transfer of whole LN microenvironment overcomes the defect in ILN development in nf{kappa}b2–/– mice and shows that NF-{kappa}B2 has an important function during lymphocyte homing to LN.

Transendothelial migration of lymphocytes to peripheral LNs occurs through an adhesion cascade in several steps: 1) rolling via L-selectin+ lymphocytes interacting with PNAd+ endothelium; 2) lymphocyte activation by chemokine receptors; 3) sticking via LFA-1, diapedesis, and homing to the LN (45). The interaction between L-selectin+ lymphocytes and PNAd in HEVs is essential for lymphocyte traffic to PLNs, for l-selectin–/– mice have a dramatic reduction in size and cellularity of peripheral LNs due to reduced influx of lymphocytes via HEVs (46). This phenotype is similar to what we observed in nf{kappa}b2–/– ILNs, but in the latter is due to NF-{kappa}B2 regulating the expression of the L-selectin ligands GlyCAM-1 and CD34 and the sulfotransferase HEC-GlcNAc6ST, required for lumenal expression of the formers. Importantly, the endothelial vessels are less organized in nf{kappa}b2–/– ILNs compared with WT ILNs, indicating that LT{alpha}1{beta}2/LT{beta}R/NF-{kappa}B2 signaling between lymphocytes and endothelial cells might be required for full development of the HEV network. Alternatively, NF-{kappa}B2 might regulate the expression of signals from the stroma to the endothelium that stimulate HEV organization and growth. The factors that mediate stromal cell-endothelial cell communication are not well characterized. LT{beta}R is expressed on human HEVs (12). Lack of appropriate reagents had precluded LT{beta}R identification in mouse HEVs.

Overexpression of LT{alpha}3 and LT{alpha}1{beta}2 or chemokines CXCL13 and CCL21 in mouse pancreas induces the development of ectopic lymphoid tissue, emphasizing the connection between chronic inflammation and lymphoid tissue organogenesis (47, 48, 49, 50, 51, 52). Congruently with our results, overexpression of LT{alpha}1{beta}2, but no LT{alpha}3, specifically induces the expression of PNAd and HEC-GlcNAc6ST (51, 52).

In contrast to previous work showing that NF-{kappa}B2 has a role in posttranscriptional regulation of VCAM-1, the mRNA and protein levels of VCAM-1 showed no differences between nf{kappa}b2–/– and WT ILNs (Fig. 5, E and F) (data not shown), suggesting that NF-{kappa}B2-independent signals might regulate the expression of this molecule in vivo (20).

NF-{kappa}B2 regulates the expression of the homing chemokines CXCL13, CCL21, and CCL19. However, the phenotype of the nf{kappa}b2–/– mice is milder than the cxcl13–/– or cxcr5–/– mice, for the latter develop only cervical, facial, and mesenteric LNs (11, 53). In contrast, plt/plt mice only occasionally lack a LN (3). CXCL13 acts as a retention factor for lymphocytes, suggesting that the reduced expression of this chemokine in nf{kappa}b2–/– mice could lead to difficulties in retaining B cells within the LN microenvironment and making them unable to migrate to the LN cortex and organize in B cell follicles (11, 53). As previously indicated, T cells express significantly higher levels of CCR7 than B cells and respond better to low concentration of CCL21, thus explaining the low numbers of B cells present in nf{kappa}b2–/– ILNs (9, 54).

In vivo studies blocking LT{beta}R signaling during mouse embryogenesis have shown that the development of peripheral LNs occurs along the anterior-posterior axis of the body (55). ILNs begin to develop at embryonic day 16 (E16), followed by popliteal LNs at E17-E18. PPs develop between E16 and P1, and nasal-associated lymphoid tissue (NALT) from P0.5 to P7 (7). The results presented in this work indicate a function for NF-{kappa}B2 in lymphocyte homing to mature LNs. However, the fact that nf{kappa}b2–/– mice lack popliteal LNs, together with recent reports showing that these mice also lack PPs and have very small NALT, indicate that all the secondary lymphoid tissues that develop around E16 onward are markedly affected, demonstrating an important function for NF-{kappa}B2 at this developmental stage (7, 25, 27, 56).

Congruently with our results, mice overexpressing NF-{kappa}B2/p52, such as p100–/– mice, develop very large LNs (57). Collectively, our results demonstrate that NF-{kappa}B2 p52, together with its transcriptional partners RelB and RelA, and the kinases NIK and IKK{alpha}, has an important function in the LT{beta}R-driven gene expression program regulating cell adhesion molecules and chemokines in stromal and endothelial cells required for lymphocyte trafficking and recruitment to LNs (Fig. 8) (30, 31, 56).



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 8. Model of action of p52-containing complexes in stromal cells. p52/RelB and p52/RelA regulate the expression of CXCL13, CCL21, and CCL19, and the cell adhesion molecules MAdCAM-1, CD34, and GlyCAM-1. See text.

 
The analysis of LN development in different nf{kappa}b-deficient mouse strains shows that absence of NF-{kappa}B1 p105/p50 results in minimal changes in LN structure. Lack of RelA results in absence of LNs and PPs due to defects in stromal cells (33). Similarly, relb–/– neonate mice develop rudimentary LNs and lack PPs, and lymphocyte homing to NALT is impaired (25, 27). Thus, a hierarchy of NF-{kappa}B complexes necessary for LN organogenesis can be drawn with RelA- and RelB-containing complexes being essential and p52/RelA-p52/RelB also being necessary, although to a lesser extent. In the absence of NF-{kappa}B2/p52, NF-{kappa}B1 p50/RelA and p50/RelB heterodimers might partially compensate the absence of the former. A functional redundancy has been previously shown between p50 and p52, while RelA and RelB are unable to substitute each other, indicating that they regulate gene expression with high specificity (58, 59).

Our current model of LN development in nf{kappa}b2–/– mice indicates that colonization of LN anlagen by inducer cells occurs normally. However, the cross talk between inducer and organizer cells through LT{beta}R results in activation of the classical NF-{kappa}B pathway only, with a subsequent low expression of adhesion molecules and chemokines. Therefore, the time required to reach the critical mass of bone marrow-derived cells into the LN anlagen is longer in nf{kappa}b2–/– embryos than in WT. We believe that a critical number of LT{alpha}1{beta}2+ cells needs to be recruited to LNs in order for these organs to develop and organize the full structure. Consequently, the LNs that develop late during embryogenesis will be more affected than the ones that develop early. In addition, low influx and retention of lymphocytes to nf{kappa}b2–/– ILNs result in either very small or rudimentary organs. Analysis of different LNs in nf{kappa}b2–/– mice shows that most of these organs have a reduced size and cellularity, contain low numbers of B cells, but overall are not affected as ILNs.

Our studies emphasize the role of the stroma and the endothelium in the formation of ectopic lymphoid tissue in chronic inflammatory diseases such as rheumatoid arthritis, thyroid autoimmune disease, and Sjogren’s syndrome (60, 61, 62, 63).


    Acknowledgments
 
We are indebted to Sonia Parnell and Dee McLoughlin for technical support, and Ravinder Suniara for invaluable help during this work. We are grateful to Anne-Gaelle Borycki for advice and helpful comments on this manuscript.


    Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 The work in J.C.’s laboratory was supported by the Medical Research Council Centre for Immune Regulation, the University of Birmingham Medical School, Celltech Group (Berkshire, U.K.), and The Royal Society. A Medical Research Council Programme Grant supported the work of E.J. and G.A. A.E. was supported by a Medical Research Council Career Development Award. D.C., R.J., and A.W. were supported by Medical Research Council studentships. Additional support to R.J. was provided by Celltech Group. Back

2 Address correspondence and reprint requests to Dr. Jorge Caamaño, Medical Research Council Centre for Immune Regulation, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT U.K. E-mail address: J.Caamano{at}bham.ac.uk Back

3 Abbreviations used in this paper: LN, lymph node; E, embryonic day; GlyCAM-1, glycosylation-dependent cell adhesion molecule; HEC-GlcNAc6ST, high endothelial cell-GlcNAc6 sulfotransferase; HEV, high endothelial venule; IKK, I{kappa}B kinase; ILN, inguinal LN; LT, lymphotoxin; MAdCAM-1, mucosal addressin cell adhesion molecule-1; NALT, nasal-associated lymphoid tissue; NIK, NF-{kappa}B-inducing kinase; P, postnatal day; PNAd, peripheral node addressin; PP, Peyer’s patch; Sq, semiquantitative; TRANCE, TNF-related activation-induced cytokine; WT, wild type. Back

Received for publication December 11, 2003. Accepted for publication June 3, 2004.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Cupedo, T., G. Kraal, R. E. Mebius. 2002. The role of CD45+CD4+CD3 cells in lymphoid organ development. Immunol. Rev. 189:41.[Medline]
  2. Yoshida, H., A. Naito, J. Inoue, M. Satoh, S. M. Santee-Cooper, C. F. Ware, A. Togawa, S. Nishikawa. 2002. Different cytokines induce surface lymphotoxin-{alpha}{beta} on IL-7 receptor-{alpha} cells that differentially engender lymph nodes and Peyer’s patches. Immunity 17:823.[Medline]
  3. Luther, S. A., K. M. Ansel, J. G. Cyster. 2003. Overlapping roles of CXCL13, interleukin 7 receptor {alpha}, and CCR7 ligands in lymph node development. J. Exp. Med. 197:1191.[Abstract/Free Full Text]
  4. Ohl, L., G. Henning, S. Krautwald, M. Lipp, S. Hardtke, G. Bernhardt, O. Pabst, R. Forster. 2003. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J. Exp. Med. 197:1199.[Abstract/Free Full Text]
  5. Kim, D., R. E. Mebius, J. D. MacMicking, S. Jung, T. Cupedo, Y. Castellanos, J. Rho, B. R. Wong, R. Josien, N. Kim, et al 2000. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192:1467.[Abstract/Free Full Text]
  6. Dougall, W. C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, et al 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13:2412.[Abstract/Free Full Text]
  7. Mebius, R. E.. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3:292.[Medline]
  8. Mebius, R. E., P. Streeter, S. Michie, E. Butcher, I. Weissman. 1996. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+CD3 cells to colonize lymph nodes. Proc. Natl. Acad. Sci. USA 93:11019.[Abstract/Free Full Text]
  9. Okada, T., V. N. Ngo, E. H. Ekland, R. Forster, M. Lipp, D. R. Littman, J. G. Cyster. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer’s patches. J. Exp. Med. 196:65.[Abstract/Free Full Text]
  10. Ebisuno, Y., T. Tanaka, N. Kanemitsu, H. Kanda, K. Yamaguchi, T. Kaisho, S. Akira, M. Miyasaka. 2003. Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer’s patches and affects B cell trafficking across high endothelial venules. J. Immunol. 171:1642.[Abstract/Free Full Text]
  11. Ansel, K., V. Ngo, P. Hyman, S. Luther, R. Forster, J. Sedgwick, J. Browning, M. Lipp, J. G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309.[Medline]
  12. Gommerman, J. L., J. L. Browning. 2003. Lymphotoxin/Light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3:642.[Medline]
  13. Fu, Y.-X., D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:399.[Medline]
  14. Kuprash, D., M. Alimzhanov, A. Tumanov, A. Anderson, K. Pfeffer, S. Nedospasov. 1999. TNF and lymphotoxin {beta} cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes. J. Immunol. 163:6575.[Abstract/Free Full Text]
  15. Tumanov, A. V., S. I. Grivennikov, A. N. Shakhov, S. A. Rybtsov, E. P. Koroleva, J. Takeda, S. A. Nedospasov, D. V. Kuprash. 2003. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195:106.[Medline]
  16. Ghosh, S., M. Karin. 2002. Missing pieces in the NF-{kappa}B puzzle. Cell 109:S81.
  17. Li, Q., I. M. Verma. 2002. NF-{kappa}B regulation in the immune system. Nat. Rev. Immunol. 2:725.[Medline]
  18. Caamano, J., C. A. Hunter. 2002. NF-{kappa}B family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15:414.[Abstract/Free Full Text]
  19. Pomerantz, J. L., D. Baltimore. 2002. Two pathways to NF-{kappa}B. Mol. Cell 10:693.[Medline]
  20. Dejardin, E., N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, D. R. Green. 2002. The lymphotoxin-{beta} receptor induces different patterns of gene expression via two NF-{kappa}B pathways. Immunity 17:525.[Medline]
  21. Lin, Y., L. Wu, H. Wesche, C. Arthur, J. White, D. Goeddel, R. Schreiber. 2001. Defective lymphotoxin-{beta}-receptor-induced NF-{kappa}B transcriptional activity in NIK-deficient mice. Science 291:2162.[Abstract/Free Full Text]
  22. Mordmuller, B., D. Krappmann, M. Esen, E. Wegener, C. Scheidereit. 2003. Lymphotoxin and lipopolysaccharide induce NF-{kappa}B-p52 generation by a co-translational mechanism. EMBO Rep. 4:82.[Medline]
  23. Muller, J. R., U. Siebenlist. 2003. Lymphotoxin {beta} receptor induces sequential activation of distinct NF-{kappa}B factors via separate signaling pathways. J. Biol. Chem. 278:12006.[Abstract/Free Full Text]
  24. Yamada, T., T. Mitani, K. Yorita, D. Uchida, A. Matsushima, K. Iwamasa, S. Fujita, M. Matsumoto. 2000. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-{kappa}B-inducing kinase. J. Immunol. 165:804.[Abstract/Free Full Text]
  25. Yilmaz, Z. B., D. S. Weih, V. Sivakumar, F. Weih. 2003. RelB is required for Peyer’s patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22:121.[Medline]
  26. Xiao, G., E. Harhaj, S. C. Sun. 2001. NF-{kappa}B-inducing kinase regulates the processing of NF-{kappa}B2 p100. Mol. Cell 7:401.[Medline]
  27. Weih, F., J. Caamaño. 2003. Regulation of secondary lymphoid organ development by the NF-{kappa}B signal transduction pathway. Immunol. Rev. 195:91.[Medline]
  28. Caamaño, J., C. Rizzo, S. Durham, D. Barton, C. Raventos-Suarez, C. Snapper, R. Bravo. 1998. Nuclear factor (NF)-{kappa}B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185.[Abstract/Free Full Text]
  29. Franzoso, G., L. Carlson, L. Poljak, E. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, et al 1998. Mice deficient in nuclear factor (NF)-{kappa}B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147.[Abstract/Free Full Text]
  30. Poljak, L., L. Carlson, K. Cunningham, M. Kosco-Vilbois, U. Siebenlist. 1999. Distinct activities of p52/NF-{kappa}B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J. Immunol. 163:6581.[Abstract/Free Full Text]
  31. Weih, D. S., Z. B. Yilmaz, F. Weih. 2001. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167:1909.[Abstract/Free Full Text]
  32. Weih, F., D. Carrasco, S. Durham, D. Barton, C. Rizzo, R. P. Ryseck, S. Lira, R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-{kappa}B/Rel family. Cell 80:331.[Medline]
  33. Alcamo, E., N. Hacohen, L. Schulte, P. Rennert, R. Hynes, D. Baltimore. 2002. Requirement of the NF-{kappa}B family member RelA in the development of secondary lymphoid organs. J. Exp. Med. 195:233.[Abstract/Free Full Text]
  34. Schmidt-Ullrich, R., T. Aebischer, J. Hulsken, W. Birchmeier, U. Klemm, C. Scheidereit. 2001. Requirement of NF-{kappa}B/Rel for the development of hair follicles and other epidermal appendices. Development 128:3843.[Abstract/Free Full Text]
  35. Fagarasan, S., R. Shinkura, T. Kamata, F. Nogaki, K. Ikuta, K. Tashiro, T. Honjo. 2000. Alymphoplasia (aly)-type nuclear factor {kappa}B-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J. Exp. Med. 191:1477.[Abstract/Free Full Text]
  36. Matsumoto, M., K. Iwamasa, P. Rennert, T. Yamada, R. Suzuki, A. Matsushima, M. Okabe, S. Fujita, M. Yokoyama. 1999. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-{alpha}-deficient mice and alymphoplasia (aly) mice defined by chimeric analysis. J. Immunol. 163:1584.[Abstract/Free Full Text]
  37. Senftleben, U., Y. Cao, G. Cao, F. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S.-C. Sun, M. Karin. 2001. Activation of IKK{alpha} of a second evolutionary conserved, NF-{kappa}B signalling pathway. Science 293:1495.[Abstract/Free Full Text]
  38. Koike, R., T. Watanabe, H. Satoh, C. S. Hee, K. Kitada, T. Kuramoto, T. Serikawa, S. Miyawaki, M. Miyasaka. 1997. Analysis of expression of lymphocyte homing-related adhesion molecules in ALY mice deficient in lymph nodes and Peyer’s patches. Cell. Immunol. 180:62.[Medline]
  39. Mebius, R. E., J. Breve, G. Kraal, P. R. Streeter. 1993. Developmental regulation of vascular addressin expression: a possible role for site-associated environments. Int. Immunol. 5:443.[Abstract/Free Full Text]
  40. Rothkotter, H. J., R. Pabst. 1990. Autotransplantation of lymph node fragments: structure and function of regenerated tissue. Scand. J. Plast. Reconstr. Surg. Hand Surg. 24:101.[Medline]
  41. Boermans, H. J., D. H. Percy, T. Stirtzinger, B. A. Croy. 1992. Engraftment of severe combined immune deficient/beige mice with bovine foetal lymphoid tissues. Vet. Immunol. Immunopathol. 34:273.[Medline]
  42. Hemmerich, S., A. Bistrup, M. S. Singer, A. van Zante, J. K. Lee, D. Tsay, M. Peters, J. L. Carminati, T. J. Brennan, K. Carver-Moore, et al 2001. Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 15:237.[Medline]
  43. Hiraoka, N., B. Petryniak, J. Nakayama, S. Tsuboi, M. Suzuki, J. C. Yeh, D. Izawa, T. Tanaka, M. Miyasaka, J. B. Lowe, M. Fukuda. 1999. A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewisx, an L-selectin ligand displayed by CD34. Immunity 11:79.[Medline]
  44. Claudio, E., K. Brown, S. Park, H. Wang, U. Siebenlist. 2002. BAFF-induced NEMO-independent processing of NF-{kappa}B2 in maturing B cells. Nat. Immunol. 3:958.[Medline]
  45. Warnock, R. A., S. Askari, E. C. Butcher, U. H. von Andrian. 1998. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med. 187:205.[Abstract/Free Full Text]
  46. Arbones, M. L., D. C. Ord, K. Ley, H. Ratech, C. Maynard-Curry, G. Otten, D. J. Capon, T. F. Tedder. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1:247.[Medline]
  47. Kratz, A., A. Campos-Neto, M. S. Hanson, N. H. Ruddle. 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183:1461.[Abstract/Free Full Text]
  48. Luther, S., T. Lopez, W. Bai, D. Hanahan, J. G. Cyster. 2000. BLC expression in pancreatic islets causes B cell recruitment aand lymphotoxin-dependent lymphoid neogenesis. Immunity 12:471.[Medline]
  49. Luther, S. A., A. Bidgol, D. C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, J. G. Cyster. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424.[Abstract/Free Full Text]
  50. Chen, S. C., G. Vassileva, D. Kinsley, S. Holzmann, D. Manfra, M. T. Wiekowski, N. Romani, S. A. Lira. 2002. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:1001.[Abstract/Free Full Text]
  51. Drayton, D. L., X. Ying, J. Lee, W. Lesslauer, N. H. Ruddle. 2003. Ectopic LT{alpha}{beta} directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197:1153.[Abstract/Free Full Text]
  52. Drayton, D. L., K. Chan, W. Lesslauer, J. Lee, X. Y. Ying, N. H. Ruddle. 2002. Lymphocyte traffic in lymphoid organ neogenesis: differential roles of Lt{alpha} and LT{alpha}{beta}. Adv. Exp. Med. Biol. 512:43.[Medline]
  53. Förster, R., A. Mattis, E. Kremmer, E. Wolf, G. Brem, M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037.[Medline]
  54. Tang, M. L., D. A. Steeber, X. Q. Zhang, T. F. Tedder. 1998. Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways. J. Immunol. 160:5113.[Abstract/Free Full Text]
  55. Rennert, P., D. James, F. Mackay, J. Browning, P. Hochman. 1998. Lymph node genesis is induced by signaling through the lymphotoxin {beta} receptor. Immunity 9:71.[Medline]
  56. Paxian, S., H. Merkle, M. Riemann, M. Wilda, G. Adler, H. Hameister, S. Liptay, K. Pfeffer, R. M. Schmid. 2002. Abnormal organogenesis of Peyer’s patches in mice deficient for NF-{kappa}B1, NF-{kappa}B2, and Bcl-3. Gastroenterology 122:1853.[Medline]
  57. Ishikawa, H., D. Carrasco, E. Claudio, R. P. Ryseck, R. Bravo. 1997. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-{kappa}B2. J. Exp. Med. 186:999.[Abstract/Free Full Text]
  58. Iotsova, V., J. Caamaño, J. Loy, Y. Yang, A. Lewin, R. Bravo. 1997. Osteopetrosis in mice lacking NF-{kappa}B1 and NF-{kappa}B2. Nat. Med. 3:1285.[Medline]
  59. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E. Shores, K. Brown, A. Leonardi, T. Tran, B. Boyce, U. Siebenlist. 1997. Requirement for NF-{kappa}B in osteoclast and B-cell development. Genes Dev. 11:3482.[Abstract/Free Full Text]
  60. Amft, N., S. J. Curnow, D. Scheel-Toellner, A. Devadas, J. Oates, J. Crocker, J. Hamburger, J. Ainsworth, J. Mathews, M. Salmon, et al 2001. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren’s syndrome. Arthritis Rheum. 44:2633.[Medline]
  61. Armengol, M. P., C. B. Cardoso-Schmidt, M. Fernandez, X. Ferrer, R. Pujol-Borrell, M. Juan. 2003. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170:6320.[Abstract/Free Full Text]
  62. Takemura, S., A. Braun, C. Crowson, P. J. Kurtin, R. H. Cofield, W. M. O’Fallon, J. J. Goronzy, C. M. Weyand. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167:1072.[Abstract/Free Full Text]
  63. Weyand, C. M., P. J. Kurtin, J. J. Goronzy. 2001. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am. J. Pathol. 159:787.[Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
L. A. Madge, M. S. Kluger, J. S. Orange, and M. J. May
Lymphotoxin-{alpha}1{beta}2 and LIGHT Induce Classical and Noncanonical NF-{kappa}B-Dependent Proinflammatory Gene Expression in Vascular Endothelial Cells
J. Immunol., March 1, 2008; 180(5): 3467 - 3477.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Tucker, K. O'Donnell, M. Fuchsberger, A. A. Hilton, D. Metcalf, K. Greig, N. A. Sims, J. M. Quinn, W. S. Alexander, D. J. Hilton, et al.
A Novel Mutation in the Nfkb2 Gene Generates an NF-{kappa}B2 "Super Repressor"
J. Immunol., December 1, 2007; 179(11): 7514 - 7522.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Guo, D. Weih, E. Meier, and F. Weih
Constitutive alternative NF-{kappa}B signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen
Blood, October 1, 2007; 110(7): 2381 - 2389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. White, D. Carragher, S. Parnell, A. Msaki, N. Perkins, P. Lane, E. Jenkinson, G. Anderson, and J. H. Caamano
Lymphotoxin a-dependent and -independent signals regulate stromal organizer cell homeostasis during lymph node organogenesis
Blood, September 15, 2007; 110(6): 1950 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. M. Chilton and T. C. Mitchell
CD8 T Cells Require Bcl-3 for Maximal Gamma Interferon Production upon Secondary Exposure to Antigen
Infect. Immun., July 1, 2006; 74(7): 4180 - 4189.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Lo, S. Basak, E. S. James, R. S. Quiambo, M. C. Kinsella, M.-L. Alegre, F. Weih, G. Franzoso, A. Hoffmann, and Y.-X. Fu
Coordination between NF-{kappa}B family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues
Blood, February 1, 2006; 107(3): 1048 - 1055.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carragher, D.
Right arrow Articles by Caamaño, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carragher, D.
Right arrow Articles by Caamaño, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS